Target Name: MIR1185-2
NCBI ID: G100302209
Review Report on MIR1185-2 Target / Biomarker Content of Review Report on MIR1185-2 Target / Biomarker
MIR1185-2
Other Name(s): MicroRNA 1185-2 | hsa-miR-1185-5p | hsa-miR-1185-2-3p | MIRN1185-2 | microRNA 1185-2 | mir-1185-2 | hsa-mir-1185-2

MIR1185-2: A Drug Target / Disease Biomarker

MIR1185-2 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the MIR family of proteins, which are known for their role in the regulation of inflammation and cellular signaling.

One of the functions of MIR1185-2 is to regulate the production of pro-inflammatory cytokines, which are important mediators of inflammation and tissue damage. MIR1185-2 has been shown to interact with several different cytokines, including TNF-alpha, IL-1, and IL-6.

In addition to its role in cytokine regulation, MIR1185-2 has also been shown to play a key role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the reasons for the interest in MIR1185-2 is its potential as a drug target. Because MIR1185-2 is involved in the regulation of pro-inflammatory cytokines, targeting this protein with small molecules or other compounds that can modulate its activity could potentially lead to the development of new treatments for a variety of diseases.

One approach to targeting MIR1185-2 is to use small molecules that can modulate its activity. One such approach is the use of inhibitors of the nuclear factor kappa B (NFkB), which is a protein that is involved in the regulation of multiple cellular processes, including inflammation and cell survival.

Nuclear factor kappa B is a protein that is expressed in various tissues of the body and is involved in the regulation of multiple cellular processes, including the production of pro-inflammatory cytokines. MIR1185-2 is known to interact with NFkB, and inhibitors of NFkB have been shown to be effective in modulating the activity of MIR1185-2.

Another approach to targeting MIR1185-2 is to use antibodies that can specifically recognize and target the protein. One such approach is the use of monoclonal antibodies (MCAs), which are antibodies that are produced by a single cell and can be directed to specific protein targets.

MCAs have been shown to be effective in targeting MIR1185-2 and modulating its activity. By using antibodies that recognize MIR1185-2, researchers have been able to block its activity and demonstrate that this protein plays a key role in the regulation of pro-inflammatory cytokines.

In conclusion, MIR1185-2 is a protein that is involved in the regulation of multiple cellular processes and has been shown to play a key role in the development and progression of several diseases. As a potential drug target, MIR1185-2 is an attractive target for the development of new treatments for a variety of conditions. The use of small molecules or antibodies that can modulate its activity could lead to the development of new treatments for a range of diseases.

Protein Name: MicroRNA 1185-2

The "MIR1185-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1185-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2